JOHAS Tohoku Rosai Hospital
Sendai Shi, Miyagi, Japan
General hospital in Sendai
4 Chome-3-21 Dainohara, Aoba Ward, Sendai, Miyagi 981-8563
About JOHAS Tohoku Rosai Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Shire
3
Arena Pharmaceuticals
2
Pfizer
2
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
2
Gilead Sciences
1
Japan Clinical Cancer Research Organization
1
Takeda
1
Clinical Trials at JOHAS Tohoku Rosai Hospital
During the past decade, JOHAS Tohoku Rosai Hospital conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 5 clinical trials were completed, i.e. on
average, 55.6% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 5 clinical trials were completed. i.e. 166.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Phase III Study of Docetaxel + S-1 vs. S-1 for Advanced Gastric Cancer
2006-03-01
2010-10-01
Completed
628
Tegafur-Uracil or Observation in Treating Patients With Stage II Colorectal Cancer That Has Been Completely Removed By Surgery
2006-10-01
2016-09-01
Completed
2,025
Identifying Prognostic Factors in Patients Receiving Tegafur-Uracil for Stage II Colon Cancer That Was Completely Removed By Surgery
2006-10-01
2016-09-01
Completed
1,111
Safety and Efficacy of Selonsertib in Adults With Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis
2017-02-13
2019-06-19
Terminated
808
Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis
2017-12-05
2020-10-06
Terminated
279
A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
2018-02-27
2023-12-31
Active, not recruiting
557
An Efficacy and Safety Study of Ontamalimab as Maintenance Therapy in Participants With Moderate to Severe Ulcerative Colitis
2018-04-04
2021-07-01
Completed
366
Phase 3 Study of Cx601 in Participants With Complex Perianal Fistulising Crohn's Disease
2019-03-06
2023-02-10
Completed
22
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "JOHAS Tohoku Rosai Hospital" #1 sponsor was "Shire" with 3 trials, followed by "Arena Pharmaceuticals" with 2 trials
sponsored, "Pfizer" with 2 trials sponsored, "Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan" with 2 trials sponsored and "Gilead Sciences"
with 2 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "JOHAS Tohoku Rosai Hospital"
#1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator, "Tokyo Medical and Dental University" with 2 trials as a collaborator and "Korean Cancer Study Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at JOHAS Tohoku Rosai Hospital
According to Clinical.Site data, the most researched conditions in "JOHAS Tohoku Rosai Hospital" are
"Ulcerative Colitis" (7 trials), "Colorectal Cancer" (2 trials), "Complex Perianal Fistulas in Adult Participants With Crohn's Disease" (1 trials), "Crohn's Disease" (1 trials) and "Gastric Cancer" (1 trials). Many other conditions were trialed in "JOHAS Tohoku Rosai Hospital" in a lesser frequency.
Clinical Trials Intervention Types at JOHAS Tohoku Rosai Hospital
Most popular intervention types in "JOHAS Tohoku Rosai Hospital" are "Drug" (11 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Etrasimod" (4 trials), "Ontamalimab" (2 trials), "UFT adjuvant chemotherapy" (2 trials) and "25 mg Ontamalimab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at JOHAS Tohoku Rosai Hospital
The vast majority of trials in "JOHAS Tohoku Rosai Hospital" are
12 trials for "All" genders.
Clinical Trials Status at JOHAS Tohoku Rosai Hospital
Currently, there are NaN active trials in "JOHAS Tohoku Rosai Hospital".
undefined are not yet recruiting,
2 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in JOHAS Tohoku Rosai Hospital,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in JOHAS Tohoku Rosai Hospital, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 10 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".